ZEISS Quality Innovation Days: April 15 – 19, 2024

Be there when industry experts give exciting insights into different applications and trends in 90 minutes on various theme days.

Festo liquid dispensing: going fast and slow

Dispensing liquid with Festo equipment developed for automation can really be adapted to your needs

“We need to build flexible operating theatres”

Flexible operating theatres, micro-sensors on surgeons to monitor their well-being and 3D images projected onto organs to be operated on. These are a few ideas ...

Swedish pavilion with healthcare companies at Ukraine fair – “Ukraine is being rebuilt right now”

Private companies and public authorities are both needed in the reconstruction of Ukraine, said Minister for Health Care, Acko Ankarberg Johansson, in her openi...

Acquisition of consulting company Key2Compliance

The Swedish company Key2Compliance, offering services in fields such as pharma and Medtech, has been acquired by German GBA Group.

Mångmiljardaffär i jakten på nästa blockbuster inom cancer

Bristol Myers Squibb betalar upp till 11,1 miljarder dollar, motsvarande 106 miljarder kronor, för att köpa in sig i en av de hetaste läkemedelskandidaterna inom immunonkologi.

New study: Post-Covid symptoms are common even after mild Covid-19

According to researchers at the University of Gothenburg, loss of smell and taste, shortness of breath and chest symptoms are the most common complaints after a...

Unexpected study results on testosterone – no reduction in fracture risk

Testosterone treatment is known to increase bone density and bone quality. However, a study now suggests that supplementation with the male sex hormone does not...

Ny vd hos Index Pharmaceuticals

I januari 2023 får Index Pharmaceuticals en ny vd. Jenny Sundqvist efterträder Johan Giléus som varit tillförordnad vd sedan april i år.

Nytt läkemedel ska förenkla behandling av blödarsjuka

En ny typ av behandling mot hemofili, som bara behöver ges varannan månad, har godkänts av den amerikanska läkemedelsmyndigheten FDA.

Oärliga företag tar över vetenskapliga tidskrifter – ”Ett allvarligt hot”

Oseriösa företag som köper upp vetenskapliga tidskrifter och sedan höjer publiceringsavgifterna och börjar masspublicera artiklar är ett växande problem. Läs fö...

The Oresund region aims at becoming Europe’s microbiome Mecca

The Medicon Valley Alliance’s ambition: Skåne and the Copenhagen region will become world leaders in microbiome research.

Stockholm aims at becoming one of the world’s top life science regions

Regional Chair for Finance, Irene Svenonius (M), believes that Stockholm can realise the goal of becoming one of the world’s top 5 regions in life science by 2025. One step on the way to achieve this is by hosting a world-leading congress in medtech....

Zelmic

Level up your medical expertise

Learn from innovative industry speakers from leading MedTech companies at ZEISS Quality Innovation Days.

Nordic Regulatory experts: Improving biotech chances of Succ

Why is it that so many biotech companies fail? And what are the tools needed to change that fact?

Conjugate Planes in Microscopy

Knowledge Article from ZEISS.

Great Swedish innovations: Eye treatment became a feather in Pharmacia’s cap

From complicated and sometimes risky surgery to a routine procedure. Pharmacia’s injectable Healon revolutionised the field of eye surgery - and is considered by us one of the most important contemporary Swedish innovations in the field of medicine....

Promising Alzheimer’s study data sends Bioarctic stock soaring

The drug candidate lecanemab from Swedish company Bioarctic significantly slowed down the deterioration in patients with early on-set Alzheimer’s, according to ...

Sweden and Denmark – this is how they choose their strategies

Scandinavia’s two major powers in pharmaceutical research have developed strategies for growth in life science, and both countries aim to become world leaders.

Column: Repurposing as a golden ticket to approval

"Hopefully, in the end, patients will be winners by receiving on-label treatments for which benefit-risk has been properly assessed." In a column Marie Gårdmark...

Swedish and Ukrainian Medical Product Agencies sign an agreement

The Directors-General of the Swedish and Ukrainian Medical Products Agencies have signed a cooperation agreement.

Starka resultat för genterapi – pausas ändå

En ny genterapi förbättrade synen hos elva av tolv patienter med en extremt sällsynt ärftlig ögonsjukdom. Men trots de starka resultaten i en klinisk studie har...

Newly discovered gene variant linked to protection against abdominal obesity

American researchers believe they have identified a rare gene mutation that protects against abdominal obesity and metabolic syndrome. The ambition is that the ...